SLITRK2

protein-coding

SLIT and NTRK like family member 2, the group of SLIT and NTRK like family

Gene summary

This gene encodes an integral membrane protein that contains two N-terminal leucine-rich repeats domains and contains C-terminal regions similar to neurotrophin receptors. The encoded protein may play a role in modulating neurite activity. Alternatively spliced transcript variants encoding the same protein have been described.[provided by RefSeq, Feb 2010]

Previous symbols:
  • SLITL1
  • TMEM257
  • CXorf1

MANE transcript

NM_032539.5

Inheritance

XL

ClinVar variants

P:7U:121B:17

Top phenotype

Intellectual developmental disorder, X-linked 111

gnomAD constraint

pLI —, LoF o/e 0.37

Max pathogenic AF

—

Genomic locus

chrX:145,817,829-145,829,856

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~12.0 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

X-linked complex neurodevelopmental disorderLIMITED

Inheritance Pattern: XL

Disease ID:MONDO:0100148

Submitter: ClinGen

The *SLITRK2* gene encodes a transmembrane protein expressed at postsynaptic neurons that regulates neurite outgrowth and excitatory synapse formation. *SLITRK2* was first reported in relation to X‑linked complex neurodevelopmental disorder in 2022 (El Chehadeh et al., PMID: 35840571). Affected individuals present with global developmental delay, intellectual disability of variable severity, neuropsychiatric and behavioral problems (including anxiety, autism spectrum disorder, ADHD, and aggressive behavior), and motor abnormalities such as unsteady gait, spasticity, or dystonia. Additional findings in a subset of individuals include seizures, feeding difficulties, kyphoscoliosis, short stature, and nonspecific structural brain abnormalities. Eight variants (6 missense and 2 nonsense) that have been reported in seven males and one female in two publications (PMIDs: 35840571, 38283150) are included in this curation. *SLITRK2* has a single protein-coding exon, which is its last exon, and is not predicted to undergo nonsense-mediated decay. The variants were either *de novo* (in two probands) or inherited from an unaffected mother, suggestive of an X‑linked recessive pattern of inheritance. Functional studies showed that four missense variants and a nonsense variant resulting in a truncated protein had impaired membrane trafficking and/or impaired excitatory synapse-promoting effects (PMID: 35840571). Two missense variants with no evidence of altered function, a missense variant in a male proband with a likely pathogenic variant in *ARX*, and a *de novo* missense variant in a female reported three times in gnomAD, were scored 0 points. The mechanism of pathogenicity appears to be loss of function. *SLITRK2* is not strongly constrained for loss‑of‑function variation (pLI = 0.75, LOEUF = 0.58, gnomAD 4.1.1) or missense variants (Z = 2.76). This gene-disease relationship is also supported by a mouse model. *Slitrk2* conditional knockout mice exhibit memory deficits and abnormal gait, while hippocampal CA1-specific conditional knockout of Slitrk2 impaired excitatory synapse maintenance and caused abnormalities in spatial reference memory (PMID: 35840571). In summary, there is limited evidence to support the relationship between *SLITRK2* and X-linked complex neurodevelopmental disorder. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on July 2, 2025 (SOP Version 12).

intellectual developmental disorder, X-linked 111LIMITED

Inheritance Pattern: XL

Disease ID:MONDO:0957203

Submitter: Ambry Genetics

intellectual developmental disorder, X-linked 111STRONG

Inheritance Pattern: XL

Disease ID:MONDO:0957203

Submitter: PanelApp Australia

Clinical Genomic Database (CGD)

Intellectual developmental disorder, X-linked 111XL

Manifestation: Musculoskeletal; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 35840571Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to SLITRK2 variants in ClinVar

6 Conditions Cataloged
not specifiedTotal: 71
not providedTotal: 29
Intellectual developmental disorder, X-linked 111Total: 22
Intellectual disabilityTotal: 8
SLITRK2-related conditionTotal: 3
Familial renal glucosuriaTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_032539.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
7
clinvar
11
clinvar
2
clinvar
20
missense
6
clinvar
105
clinvar
4
clinvar
115
nonsense
1
clinvar
7
clinvar
8
start loss
0
frameshift
2
clinvar
2
splice donor/acceptor (+/-2bp)
0
Total07121152145

Highest pathogenic variant AF is 0.000003307179

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 41 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_032539.5RefSeqNP_115928.11MANE Select
ENST00000335565.6EnsemblENSP00000334374.51MANE Select
NM_001144003.3RefSeqNP_001137475.11Standard
NM_001144004.3RefSeqNP_001137476.11Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Neuronal System
  • Receptor-type tyrosine-protein phosphatases
  • Protein-protein interactions at synapses

Biological Process

  • axonogenesis
  • regulation of synapse organization
  • positive regulation of synapse assembly
  • synaptic membrane adhesion
  • regulation of presynapse assembly

Cellular Component

  • plasma membrane
  • integral component of membrane
  • glutamatergic synapse
  • GABA-ergic synapse

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000370490
Coding exons
1
Length
8011
Individuals with no LoFs
0
Homozygous LoFs
0
Heterozygous LoFs
0
Defined
0
p
0.00
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense2.202123230.6560.00002475528
Missense (PolyPhen)50118.150.42322176
Synonymous-0.7251501391.080.00001121724
Loss of Function2.54718.90.3700.00000164315

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)00.0absent
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: It is involved in synaptogenesis and promotes excitatory synapse differentiation (PubMed:27273464, PubMed:27812321). Suppresses neurite outgrowth (By similarity). {ECO:0000250|UniProtKB:Q810C0, ECO:0000269|PubMed:27273464, ECO:0000269|PubMed:27812321}.;

Recessive Scores

pRec
0.117

Intolerance Scores

LoFtool
0.279
RVIS EVS
-0.78
RVIS percentile EVS
12.88

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Indispensability pred.
N
Indispensability score
0.215

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.